Embree Financial Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$568K Sell
8,231
-4,618
-36% -$319K 0.09% 132
2025
Q1
$892K Sell
12,849
-1,213
-9% -$84.2K 0.15% 97
2024
Q4
$1.21M Buy
+14,062
New +$1.21M 0.21% 75